Medizone Announces a Second Round of Trials Have Begun.
Medizone anticipates completion of these new studies by early July, whereupon it intends to commence field trials in preparation for marketing later this calendar year. To learn more about these global health concerns the AsepticSure system addresses, please visit the company’s web site: www.medizoneint.com. From the home page, go to AsepticSure. The presentation offered is a detailed analysis of the global health problems caused by hospital derived nosocomial infections.
Medizone International, Inc., is a research and development company engaged in developing its’ AsepticSure technology to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure. If current trials continue to proceed successfully they will be followed by a hospital mock-up and then hospital beta testing of the production prototype. Initial sales are targeted to commence in the 4th quarter of this year.
This Press Release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.
Investor Relations 800-953-3350 / web site: www.medizoneint.com E-mail: email@example.com
SOURCE Medizone International, Inc.